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Background: The recent development of techniques to measure high-frequency acoustic emission 
(AE) from knees has opened up the possibility of identifying AE features which reflect the integrity of 
interactions between joint components during weight bearing movement. The objective of this study 
was to determine whether novel candidate biomarkers, based on AE measurements, can be identified 
for future use in clinical trials and stratified medicine applications for knee osteoarthritis (OA). We 
focused on testing the reproducibility of candidate AE biomarkers and their association with other 
markers, using a cohort approach. 
 
Methods: Participants with knee pain and KL scores between 1-4 were recruited from local NHS 
primary and secondary care organisations. AE data were collected and analysed from the worse knee, 
as identified by each participant, using our established sit-stand-sit movement protocol. Variation in 
AE measurement was analysed in 45 participants by fitting two linear mixed effects models. In 
addition to random effects terms for practitioners and visits, respectively, both models included a 
fixed effect term for the AE machines and random effects terms to capture between-participant 
variability and residual error. Associations with other markers were tested in 68 participants by fitting 
a linear mixed effects model for each candidate biomarker. The model included fixed effects for the 
covariates of interest, a participant-specific random effect that accounts for correlation between 
repeated measurements within the same individual, and a residual error term. A multiple regression 
model was developed using forward selection based on the likelihood ratio test with a cut-off for 
significance of p < 0.1. 
 
Results: Of four candidate AE biomarkers tested, AE number of hits showed the best reproducibility 
profile regarding variation within session, day to day, week to week, between practitioner, and 
between machines. AE number of hits was higher in people with KL2, 3 or 4 scores than in those with 
KL1. Hits occurred predominantly in two of the four pre-defined sit-stand movement quadrants. AE 
number of hits also showed significant associations with contralateral knee pain, and with body 
weight. The protocol used was feasible and acceptable to all participants and health professionals 
involved. 
 
Conclusion: Measurement of AE hits using a simple sit-stand-sit movement protocol offers a novel 
and convenient approach for assessing the integrity of interactions between joint components during 
weight bearing movement. AE number of hits offers a novel potential knee OA biomarker for use in 
large multicentre clinical trials of knee OA treatments. AE measurement may reflect a composite of 
knee structural changes and joint loading factors. Refinement of the method may further strengthen 
the utility of the AE approach for clinical trials. This approach may also have applications for 
monitoring knee OA in primary care. 
